SCHEMBL1630006

SCHEMBL1630006

O=C(O)c1ccccc1-n1nccc1-c1ccc(O)cc1O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.45
HTT P42858 1/20 0.45
HSP90AA1 P07900 5/20 0.44
TSHR P16473 2/20 0.41
CA12 O43570 2/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CA7 P43166 2/20 0.41
CA9 Q16790 2/20 0.41
CA14 Q9ULX7 2/20 0.41
ALDH1A1 P00352 1/20 0.41
HSD17B10 Q99714 2/20 0.40
MEN1 O00255 2/20 0.40
USP2 O75604 2/20 0.40
KMT2A Q03164 2/20 0.40
KEAP1 Q14145 2/20 0.40
NFE2L2 Q16236 2/20 0.40
POLB P06746 1/20 0.40
HSP90AB1 P08238 1/20 0.40
BRCA1 P38398 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15049636 0.81 GAA (0.45) MAPTHSP90AA1ALDH1A1MEN1USP2
SCHEMBL1630386 0.80 HSP90AA1 (0.51) HSP90AA1HSP90AB1ALOX5
SCHEMBL1631545 0.80 HSP90AA1 (0.47) HSP90AA1KMT2AALOX5
SCHEMBL1629812 0.80 HSP90AA1 (0.56) HSP90AA1MEN1KMT2AALOX5
SCHEMBL1629980 0.80 HSP90AA1 (0.49) HSP90AA1ALDH1A1HSD17B10MEN1USP2
SCHEMBL1629941 0.80 HSP90AA1 (0.67) MAPTHSP90AA1L3MBTL1KDM5AKDM4C
SCHEMBL1630409 0.79 HSP90AA1 (0.51) MAPTHSP90AA1ALDH1A1MEN1KMT2A
SCHEMBL1629175 0.78 TYR (0.48) MAPTHSP90AA1TSHRALDH1A1HSD17B10
SCHEMBL5169471 0.77 ALOX15 (0.41) MAPTHTTHSP90AA1HSD17B10MEN1
SCHEMBL1631441 0.77 HSP90AA1 (0.43) MAPTHSP90AA1ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776346-B1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2013-06-26 EP disclosed
US-7932401-B2 Heat Shock Protein 90 (HSP90) inhibitors; 5-(2-hydroxy-4-methoxyphenyl)-1-(3-nitrophenyl)-1H-pyrazole for example; antitumor agent, viral diseases, transplant rejection, cystic fibrosis, angiogenesis inhibition, infectious, autoimmune, or inflammatory diseases, ischemia, chemotherapy cytoprotectant MERCK PATENT GMBH (DE) 2011-04-26 US disclosed
US-20080085904-A1 1,5-Diphenylpyrazoles MERCK PATENT GMBH (DE) 2008-04-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085904-A1 1,5-Diphenylpyrazoles HSP90AB1, HSP90AA1, HSP90AB2P MAPT 2299/4885HTT 1129/4885HSP90AA1 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.